到 2028 年北美胰岛素市场预测 - COVID-19 影响和区域分析 - 按类型 [长效胰岛素、速效胰岛素、短效胰岛素和传统人胰岛素、浓缩胰岛素和组合胰岛素、生物仿制药胰岛素、胰高血糖素-如 Peptide-1 (GLP-1)、笔和针等]
No. of Pages: 174 | Report Code: BMIRE00027247 | Category: Life Sciences
No. of Pages: 174 | Report Code: BMIRE00027247 | Category: Life Sciences
随着北美地区糖尿病患病率的不断上升，对更先进治疗产品的需求也在不断增加。胰岛素市场上的公司积极支持公共和私人研究和学术机构鼓励研究活动。下面提到了与胰岛素市场快速技术进步相关的一些最新发展：
• 2021年10月，通化东宝药业股份有限公司的超速效胰岛素注射液BC Lispro获得国家药品监督管理局（NMPA）批准开展临床试验。目前该药物正在国内启动Ⅲ期临床试验。
• 2021 年 5 月，Bigfoot Biomedical 的 Bigfoot Unity 糖尿病管理系统获得了美国 FDA 的 510(k) 许可，该系统配备联网智能笔帽，可为采用每日多次注射 (MDI) 疗法的患者推荐胰岛素剂量。
胰岛素输送设备的此类技术进步正在推动北美胰岛素市场的增长。
北美胰岛素市场已细分为美国、加拿大和墨西哥，其中美国所占份额最大。该地区的市场增长归因于糖尿病和肥胖症患病率的上升，以及人们对糖尿病护理意识的不断增强。根据《2020 年国家糖尿病统计报告》，美国约有 3030 万人患有糖尿病，占总人口的 94%。在糖尿病人群中，约 5% 被诊断患有 1 型糖尿病，而 90-95% 患有 2 型糖尿病。在超过 3000 万患有糖尿病的美国人中，约有 740 万人依靠胰岛素来控制病情。此外，数据还显示，约8600万18岁或以上的成年人和约2310万65岁的老年人处于糖尿病前期。糖尿病也是成人失明和终末期肾病或肾衰竭的主要原因。
北美胰岛素市场分为类型和国家。根据类型，市场分为长效胰岛素、速效胰岛素、短效胰岛素和传统人胰岛素、浓缩胰岛素和组合胰岛素、生物仿制药胰岛素、胰高血糖素样肽-1 (GLP-1)、笔和针、和别的。长效胰岛素细分市场在 2022 年占据最大的市场份额。
长效胰岛素细分市场的北美胰岛素市场细分为 Levemir、来得时、basaglar 和 tresiba 。 Tresiba 细分市场在 2022 年占据最大的市场份额。
北美胰岛素市场的短效胰岛素和传统人胰岛素细分市场细分为 Novolin R、Humalin R、Insuman ， 和别的。胰岛素细分市场在 2022 年占据最大的市场份额。
北美胰岛素市场的浓缩胰岛素和组合胰岛素细分市场进一步细分为 Novomix、ryzodeg、xultophy 和 soliqua /苏利夸。 xultophy 细分市场在 2022 年占据最大的市场份额。
北美胰岛素生物仿制药市场进一步细分为甘精胰岛素生物仿制药和人胰岛素生物仿制药。甘精胰岛素生物仿制药细分市场在 2022 年占据更大的市场份额。
Biocon；礼来公司；葛兰素史克公司；默克公司有限公司；诺和诺德公司；辉瑞公司；赛诺菲；通化东宝药业有限公司；和 Wockhardt 是该地区胰岛素市场的领先公司。
Strategic insights for North America Insulin involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 23,946.85 Million |
| Market Size by 2028 | US$ 43,517.93 Million |
| Global CAGR (2022 - 2028) | 10.5% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Insulin refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Insulin Market is valued at US$ 23,946.85 Million in 2022, it is projected to reach US$ 43,517.93 Million by 2028.
As per our report North America Insulin Market, the market size is valued at US$ 23,946.85 Million in 2022, projecting it to reach US$ 43,517.93 Million by 2028. This translates to a CAGR of approximately 10.5% during the forecast period.
The North America Insulin Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Insulin Market report:
The North America Insulin Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Insulin Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Insulin Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Insulin Market
